跳至主要内容
临床试验/CTRI/2023/08/056456
CTRI/2023/08/056456已完成Unknown

A monocentric, interventional, open label clinical study to evaluate the safety and efficacy of test product (TLS-SA23) on healthy female subjects - NI

Transformative Learning Solutions Pvt Ltd0 个研究点目标入组 38 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
38

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Each subject with mild to moderate acne and with oily/ acne prone skin (based on lesion count)
  • 2. Each subject with oily acne prone skin, sebum casual level on forehead > 90µg/cm2 (mean)
  • 3. Subjects having acne based on IGA Scale.
  • 4. Subjects having spots, PIH/uneven skin tone and enlarged pores
  • 5. Subjects with other skin concern like blemishes, rashes etc.
  • 6. Subject free of excessive hair, acne, cuts, abrasions, fissures, wounds, lacerations, or any other active skin conditions on the face.
  • 7. Subject who agrees not to use any other product/treatment/home remedy/except the provided products on their face during the study period other than the test product.
  • 8.Subjects who agree not to carry out bleaching or any other procedures including facial etc. on face during the study period.
  • 9.Subjects who agree not to expose to excessive sun light. (Sun exposure not more than half an hour daily and during that time use of umbrella to cover face).
  • 10.Subjects willing to give a voluntary written informed consent, photography release and agree to come for regular follow-up.
  • 11. Subjects willing to abide by and comply with the study protocol.
  • 12. Subject to agree to remove all jewellery on/around face (e.g., necklace, earrings, if possible, nose ring), during VISIA imaging.

排除标准

  • 1. Subjects having cystic acne.
  • 2. Subjects with known skin condition that may impact the assessment.
  • 3. Subject with any other signs of significant local irritation or skin disease.
  • 4. Subject currently taking any medication, which the Investigator believes may influence the interpretation of the data.
  • 5. Subject having clinically significant systemic or cutaneous disease, chronic illness or had major surgery in the last year.
  • 6. Subjects who do not agree to remove all jewelry on/around face (e.g., necklace, earrings, if possible, nose ring), during Digital imaging.
  • 7. Subjects having hair style which covers almost the entire forehead
  • 8. Subjects undergoing any treatment of any skin condition on their face.
  • 9. Subjects not willing to discontinue other topical facial products.
  • 10. Subject allergic or sensitive to bar cleansing products, cosmetics, creams/lotions, artificial jewelry or anything else.
  • 11. Pregnant women (as confirmed by UPT) and lactating women
  • 12. Subjects on any medical treatment either systemic/topical in the past 1 month or currently taking medication including food supplements.
  • 13. Subjects with skin allergy history or atopic dermatitis or psoriasis.
  • 14. Subjects who have participated in any other clinical trial in the last 3 months.
  • 15. Subjects who were treated with Botox/filler /bio stimulatory molecules injection

研究者

发起方
Transformative Learning Solutions Pvt Ltd

相似试验